Healthcare Services Group, Inc. (HCSG) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2025)
HCSG's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
HCSG Revenue Analysis (2014–2025)
As of February 28, 2026, Healthcare Services Group, Inc. (HCSG) generated trailing twelve-month (TTM) revenue of $1.81 billion, reflecting solid growth of +8.5% year-over-year. The most recent quarter (Q3 2025) recorded $464.3 million in revenue, up 1.3% sequentially.
Looking at the longer-term picture, HCSG's 5-year compound annual growth rate (CAGR) stands at +0.9%, indicating moderate growth over time. The company achieved its highest annual revenue of $2.01 billion in 2018.
Revenue diversification analysis shows HCSG's business is primarily driven by Dietary Services (55%), and Environmental Services (45%). With over half of revenue concentrated in Dietary Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including SOLV (+0.9% YoY), AMN (-8.5% YoY), and CCRN (-22.1% YoY), HCSG has underperformed the peer group in terms of revenue growth. Compare HCSG vs SOLV →
Peer Comparison
Compare HCSG's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HCSGCurrent | $1.8B | +8.5% | +0.9% | 2.6% | |
| SOLV | $8.3B | +0.9% | - | 26.2% | |
| AMN | $3.0B | -8.5% | +6.1% | -3.4% | |
| CCRN | $1.3B | -22.1% | +10.3% | -1.3% | |
| CCEL | $32M | -0.3% | +0.1% | 10.9% | |
| AMS | $28M | +17.8% | +6.6% | -9.9% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.84B | +7.1% | $239.4M | 13.0% | $48.5M | 2.6% |
| 2024 | $1.72B | +2.7% | $228.1M | 13.3% | $53.3M | 3.1% |
| 2023 | $1.67B | -1.1% | $214.7M | 12.8% | $54.7M | 3.3% |
| 2022 | $1.69B | +2.9% | $193.3M | 11.4% | $43.8M | 2.6% |
| 2021 | $1.64B | -6.7% | $230.6M | 14.0% | $64.1M | 3.9% |
| 2020 | $1.76B | -4.4% | $268.0M | 15.2% | $0 | - |
| 2019 | $1.84B | -8.4% | $227.9M | 12.4% | $77.9M | 4.2% |
| 2018 | $2.01B | +7.6% | $236.8M | 11.8% | $100.2M | 5.0% |
| 2017 | $1.87B | +19.4% | $253.6M | 13.6% | $126.9M | 6.8% |
| 2016 | $1.56B | +8.8% | $223.2M | 14.3% | $117.8M | 7.5% |
See HCSG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCSG Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare HCSG vs AGIO
See how HCSG stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is HCSG's revenue growth accelerating or slowing?
HCSG maintains +8.5% revenue growth, in line with its 5-year CAGR of +0.9%. TTM revenue stands at $1.8B. Growth rate remains consistent with historical average.
What is HCSG's long-term revenue growth rate?
Healthcare Services Group, Inc.'s 5-year revenue CAGR of +0.9% reflects the sustained expansion pattern. Current YoY growth of +8.5% is near this long-term average.
How is HCSG's revenue distributed by segment?
HCSG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.